News | December 21, 2025
Alvotech, Teva secure US settlement with Regeneron for Eylea biosimilar launch
Under the agreement, AVT06 is licensed to enter the US market in the fourth quarter of 2026
Under the agreement, AVT06 is licensed to enter the US market in the fourth quarter of 2026
This agreement will enhance Lupin’s gastroenterology portfolio and expand its presence in emerging markets
The receipt of this permission paves way for the marketing of Datopotamab Deruxtecan powder for concentrate for solution for infusion 100 mg (r-DNA origin) in India
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
Hansoh Pharma will receive an upfront payment in the low double-digit millions
India plays a critical role in Bristol Myers Squibb’s global strategy
The reform is set to modernise how medicines are developed, authorised, and made available across the EU
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
Her journey includes leading HR for large and diverse teams across sales, marketing, corporate functions, and R&D
Subscribe To Our Newsletter & Stay Updated
